{
    "clinical_study": {
        "@rank": "131228", 
        "arm_group": [
            {
                "arm_group_label": "IDP-118 Lotion", 
                "arm_group_type": "Experimental", 
                "description": "halobetasol propionate [HP] 0.01%, tazarotene [Taz] 0.045%"
            }, 
            {
                "arm_group_label": "IDP-118 Monad HP 0.01% Lotion", 
                "arm_group_type": "Active Comparator", 
                "description": "HP 0.01%"
            }, 
            {
                "arm_group_label": "IDP-118 Monad Taz 0.045% Lotion", 
                "arm_group_type": "Active Comparator", 
                "description": "Taz 0.045%"
            }, 
            {
                "arm_group_label": "IDP-118 Vehicle Lotion", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Vehicle"
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of the study is to evaluate the safety and efficacy of a topical lotion when\n      applied once daily to adult subjects with moderate to severe plaque psoriasis."
        }, 
        "brief_title": "Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis", 
        "completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Plaque Psoriasis", 
        "condition_browse": {
            "mesh_term": "Psoriasis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Key Inclusion Criteria:\n\n          -  Male or female, of any race, at least 18 years of age (inclusive).\n\n          -  Freely provides both verbal and written informed consent.\n\n          -  Has an area of plaque psoriasis appropriate for topical treatment that covers a BSA\n             of at least 3%, but no more than 12%. The face, scalp, palms, soles, axillae and\n             intertriginous areas are to be excluded in this calculation.\n\n          -  Is willing and able to avoid prolonged exposure of the treatment area to ultraviolet\n             radiation (natural and artificial) for the duration of the study.\n\n          -  Has a clinical diagnosis of psoriasis at the Baseline visit with an IGA score of 3 or\n             4. (The face, scalp, palms, soles, axillae and intertriginous areas are to be\n             excluded in this assessment, if psoriasis is present).\n\n        Key Exclusion Criteria:\n\n          -  Has spontaneously improving or rapidly deteriorating plaque psoriasis or pustular\n             psoriasis, as determined by the investigator.\n\n          -  Presents with psoriasis that was treated with prescription medication and failed to\n             respond to treatment, even partially or temporarily, as determined by the\n             investigator.\n\n          -  Presents with any concurrent skin condition that could interfere with the evaluation\n             of the treatment areas, as determined by the investigator.\n\n          -  Is pregnant, nursing an infant, or planning a pregnancy during the study period.\n\n          -  Has received treatment with any investigational drug or device within 60 days or 5\n             drug half lives (whichever is longer) prior to the Baseline visit, or is concurrently\n             participating in another clinical study with an investigational drug or device."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "210", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 22, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02045277", 
            "org_study_id": "V01-118A-201"
        }, 
        "intervention": [
            {
                "arm_group_label": "IDP-118 Lotion", 
                "intervention_name": "IDP-118 Lotion", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "IDP-118 Monad HP 0.01% Lotion", 
                "description": "Active Comparator", 
                "intervention_name": "IDP-118 Monad HP 0.01% Lotion", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "IDP-118 Monad Taz 0.045% Lotion", 
                "description": "Active Comparator", 
                "intervention_name": "IDP-118 Monad Taz 0.045% Lotion", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "IDP-118 Vehicle Lotion", 
                "description": "Vehicle", 
                "intervention_name": "IDP-118 Vehicle Lotion", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "April 30, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Encino", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91436"
                    }, 
                    "name": "Valeant Site 13"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92123"
                    }, 
                    "name": "Valeant Site 11"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Santa Rosa", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "95403"
                    }, 
                    "name": "Valeant Site 15"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Augusta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30909"
                    }, 
                    "name": "Valeant Site 10"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newnan", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30263"
                    }, 
                    "name": "Valeant Site 09"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Louisville", 
                        "country": "United States", 
                        "state": "Kentucky", 
                        "zip": "40217"
                    }, 
                    "name": "Valeant Site 08"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rockville", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "20850"
                    }, 
                    "name": "Valeant Site 04"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Clinton Twp", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48038"
                    }, 
                    "name": "Valeant Site 14"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fridley", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "55432"
                    }, 
                    "name": "Valeant Site 07"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "East Windsor", 
                        "country": "United States", 
                        "state": "New Jersey"
                    }, 
                    "name": "Valeant Site 01"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10075"
                    }, 
                    "name": "Valeant Site 03"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rochester", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "14623"
                    }, 
                    "name": "Valeant Site 17"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "High Point", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27262"
                    }, 
                    "name": "Valeant Site 02"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Austin", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78759"
                    }, 
                    "name": "Valeant Site 05"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "College Station", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77845"
                    }, 
                    "name": "Valeant Site 06"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salt Lake City", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84117"
                    }, 
                    "name": "Valeant Site 16"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lynchburg", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "24501"
                    }, 
                    "name": "Valeant Site 18"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Norfolk", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "23507"
                    }, 
                    "name": "Valeant Site 12"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "4", 
        "official_title": "A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis", 
        "overall_contact": {
            "email": "binu.alexander@valeant.com", 
            "last_name": "Binu J Alexander, MD", 
            "phone": "908-927-1756"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "The percent of subjects who experience a local skin reaction graded at a level of 3 at any point in the study", 
                "safety_issue": "Yes", 
                "time_frame": "up to 3 months"
            }, 
            {
                "measure": "The percent of subjects with at least a 2-grade improvement from Baseline in the score for each of the signs of psoriasis", 
                "safety_issue": "No", 
                "time_frame": "Up to 3 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02045277"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Valeant Pharmaceuticals International, Inc.", 
        "sponsors": {
            "collaborator": {
                "agency": "Dow Pharmaceutical Sciences", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Valeant Pharmaceuticals International, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}